Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.63B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.14B |
| 3 |
Oracle
ORCL
|
+$1.04B |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$859M |
| 5 |
S&P Global
SPGI
|
+$832M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$1.17B |
| 2 |
Trade Desk
TTD
|
+$1B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$895M |
| 4 |
Constellation Brands
STZ
|
+$861M |
| 5 |
Carvana
CVNA
|
+$851M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.43% |
| 2 | Financials | 12.09% |
| 3 | Consumer Discretionary | 8.79% |
| 4 | Healthcare | 8.71% |
| 5 | Communication Services | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Janus Henderson Small/Mid Cap Growth Alpha ETF
JSMD
$1.1B
| $55.1M | ﹤0.01% |
787,504
-62,307
| -7% | -$4.63M |
|
1727
Goldman Sachs Equal Weight US Large Cap Equity ETF
GSEW
$2.04B
| $55.1M | ﹤0.01% |
724,628
+109,093
| +18% | +$8.57M |
|
1728
Element Solutions
ESI
$9.23B
| $55.1M | ﹤0.01% |
2,436,109
+710,815
| +41% | +$18.2M |
|
1729
CNO Financial Group
CNO
$5.1B
| $55M | ﹤0.01% |
1,320,759
-131,980
| -9% | -$5.27M |
|
1730
Teradata
TDC
$2.55B
| $55M | ﹤0.01% |
2,445,163
+1,049,406
| +75% | +$28.4M |
|
|
PDCO
1731
DELISTED
Patterson Companies, Inc.
PDCO
| $54.9M | ﹤0.01% |
1,756,531
-409,444
| -19% | -$12.7M |
|
1732
iShares Core US REIT ETF
USRT
$4.64B
| $54.9M | ﹤0.01% |
952,568
+33,067
| +4% | +$1.92M |
|
|
CVSA
1733
Covista Inc
CVSA
$4.8B
| $54.9M | ﹤0.01% |
545,136
+34,354
| +7% | +$3.43M |
|
1734
Shinhan Financial Group
SHG
$35.6B
| $54.8M | ﹤0.01% |
1,709,756
-116,841
| -6% | -$3.92M |
|
|
HQH
1735
abrdn Healthcare Investors
HQH
$1.32B
| $54.8M | ﹤0.01% |
3,377,092
+159,171
| +5% | +$2.74M |
|
1736
Essent Group
ESNT
$6.33B
| $54.8M | ﹤0.01% |
949,844
-240,230
| -20% | -$13.6M |
|
1737
Main Street Capital
MAIN
$5.48B
| $54.8M | ﹤0.01% |
968,486
-2,524
| -0.3% | -$150K |
|
1738
iShares Core MSCI Pacific ETF
IPAC
$2.77B
| $54.7M | ﹤0.01% |
878,996
-16,812
| -2% | -$1.05M |
|
1739
Patterson-UTI
PTEN
$3.76B
| $54.7M | ﹤0.01% |
6,653,121
+1,011,688
| +18% | +$8.49M |
|
1740
Hess Midstream
HESM
$5.11B
| $54.7M | ﹤0.01% |
1,293,162
-460,919
| -26% | -$18.8M |
|
1741
Invesco High Yield Equity Dividend Achievers ETF
PEY
$1.17B
| $54.7M | ﹤0.01% |
2,546,250
-208,018
| -8% | -$4.49M |
|
1742
Assured Guaranty
AGO
$3.34B
| $54.4M | ﹤0.01% |
617,652
+59,086
| +11% | +$5.3M |
|
1743
John Wiley & Sons Class A
WLY
$2.66B
| $54.4M | ﹤0.01% |
1,219,720
+137,605
| +13% | +$5.81M |
|
1744
SSR Mining
SSRM
$6.48B
| $54.3M | ﹤0.01% |
5,411,025
+628,456
| +13% | +$5.8M |
|
1745
Spire
SR
$4.85B
| $54.2M | ﹤0.01% |
692,242
-76,282
| -10% | -$5.58M |
|
|
TEM
1746
Tempus AI
TEM
$9.39B
| $54.1M | ﹤0.01% |
1,121,331
+856,029
| +323% | +$46.2M |
|
1747
Vanguard Russell 3000 ETF
VTHR
$4.86B
| $54M | ﹤0.01% |
218,932
+41,378
| +23% | +$10.8M |
|
1748
Nuveen Preferred & Income Opportunities Fund
JPC
$2.9B
| $54M | ﹤0.01% |
6,780,783
-875,695
| -11% | -$6.99M |
|
1749
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund
CORP
$1.58B
| $53.9M | ﹤0.01% |
556,756
-16,178
| -3% | -$1.55M |
|
1750
Krystal Biotech
KRYS
$9.66B
| $53.8M | ﹤0.01% |
298,205
+41,930
| +16% | +$7.05M |
|
Similar funds
Morgan Stanley's Q1 2025 Portfolio in Review
As of Q1 2025, Morgan Stanley held 8,359 positions worth $1.4T, down 2% from $1.43T the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Morgan Stanley's Q1 2025 filing shows 410 new, 3,433 increased, 3,308 reduced and 270 closed positions. Its largest new stake was Sandisk: 1,632,771 shares worth $77.7M. The largest sale was Intel, an estimated $1.17B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q1 2025 buy was Sandisk: 1,632,771 shares worth $77.7M.
- Morgan Stanley added most to Invesco QQQ Trust in Q1 2025, an estimated $1.63B increase.
- Morgan Stanley's biggest Q1 2025 reduction was Intel, cutting an estimated $1.17B.
- Morgan Stanley fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $110M.
- Morgan Stanley's ten largest holdings make up 20% of its $1.4T portfolio in Q1 2025.
- Morgan Stanley opened 410 new positions and closed 270 in Q1 2025.
- Morgan Stanley's portfolio value fell 2% quarter-over-quarter to $1.4T.
Based on Morgan Stanley's 13F filing for Q1 2025, filed 15 May 2025.